Evidence for activation of KIT, pdgfrα, and PDGFRp receptors in the Ewing sarcoma family of tumorsBOZZI, Fabio; TAMBORINI, Elena; NEGRI, Tiziana et al.Cancer. 2007, Vol 109, Num 8, pp 1638-1645, issn 0008-543X, 8 p.Article

Circulating perivascular progenitors: a target of PDGFR inhibitionMANCUSO, Patrizia; MARTIN-PADURA, Ines; CALLERI, Angelica et al.International journal of cancer (Print). 2011, Vol 129, Num 6, pp 1344-1350, issn 0020-7136, 7 p.Article

Pro-fibrogenic potential of PDGF-D in liver fibrosisBORKHAM-KAMPHORST, Erawan; VAN ROEYEN, Claudia R. C; OSTENDORF, Tammo et al.Journal of hepatology. 2007, Vol 46, Num 6, pp 1064-1074, issn 0168-8278, 11 p.Article

Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disordersBOCHTLER, T; KIRSCH, M; MAIER, B et al.Leukemia. 2012, Vol 26, Num 4, pp 728-735, issn 0887-6924, 8 p.Article

PDGFRα, PDGFRβ and KIT expression/activation in conventional chondrosarcomaLAGONIGRO, M. S; TAMBORINI, E; PIEROTTI, M. A et al.Journal of pathology. 2006, Vol 208, Num 5, pp 615-623, issn 0022-3417, 9 p.Article

Characterization of two monoclonal antibodies reactive with the external domain of the platelet-derived growth factor receptorRÖNNSTRAND, L; TERRACIO, L; CLAESSON-WELSH, L et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 21, pp 10429-10435, issn 0021-9258Article

Platelet-derived growth factor receptor regulates myeloid and monocytic differentiation of HL-60 cellsREITERER, Gudrun; YEN, Andrew.Cancer research (Baltimore). 2007, Vol 67, Num 16, pp 7765-7772, issn 0008-5472, 8 p.Article

Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma : Correlation with overall survival in 105 patientsARMISTEAD, Paul M; SALGANICK, Jason; ROH, Jae S et al.Cancer. 2007, Vol 110, Num 10, pp 2293-2303, issn 0008-543X, 11 p.Article

Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinomaLI CHEN; YAN SHI; JIANG, Cheng-Ying et al.The International journal of biological markers. 2011, Vol 26, Num 2, pp 108-116, issn 0393-6155, 9 p.Article

Advances in the treatment of gastrointestinal stromal tumoursJUDSON, I; DEMETRI, G.Annals of oncology. 2007, Vol 18, issn 0923-7534, x20-x24, SUP10Conference Paper

Mutational analysis of PDGFR-RAS/MAPK pathway activation in childhood medulloblastomaGILBERTSON, Richard J; LANGDON, Jaqueline A; HOLLANDER, Andrew et al.European journal of cancer (1990). 2006, Vol 42, Num 5, pp 646-649, issn 0959-8049, 4 p.Article

Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitorDONGCHUN WANG; FENG TANG; SEN WANG et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 1, pp 173-183, issn 0344-5704, 11 p.Article

Tumor angiogenesis and novel antiangiogenic strategiesGORDON, Michael S; MENDELSON, David S; KATO, Gerry et al.International journal of cancer (Print). 2010, Vol 126, Num 8, pp 1777-1787, issn 0020-7136, 11 p.Article

Mise au point sur la prise en charge des GIST = Focus on GIST managementTARDIEU, M; DOMONT, J; CIOFFI, A et al.Bulletin du cancer. 2010, Vol 97, Num 6, pp 723-731, issn 0007-4551, 9 p.Article

A gain-of-function mutation in the PDGFR-β alters the kinetics of injury response in liver and skinKRAMPERT, Monika; HELDIN, Carl-Henrik; HEUCHEL, Rainer L et al.Laboratory investigation. 2008, Vol 88, Num 11, pp 1204-1214, issn 0023-6837, 11 p.Article

The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR -α -expressing cells through caspase-3-mediated cleavage of Mcl-1PAN, J; QUINTAS-CARDAMA, A; MANSHOURI, T et al.Leukemia. 2007, Vol 21, Num 7, pp 1395-1404, issn 0887-6924, 10 p.Article

Expression and Mutational Status of PDGFR in Thymic TumoursMEISTER, Michael; KAHL, Philip; RIEKER, Ralf J et al.Anticancer research. 2009, Vol 29, Num 10, pp 4057-4061, issn 0250-7005, 5 p.Article

PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tractROSSI, G; VALLI, R; BERTOLINI, F et al.Histopathology. 2005, Vol 46, Num 5, pp 522-531, issn 0309-0167, 10 p.Article

Les inhibiteurs de tyrosine kinase = Tyrosine kinase inhibitorsROBERT, Jacques.Bulletin du cancer. 2011, Vol 98, Num 11, pp 1321-1334, issn 0007-4551, 14 p.Article

Sunitinib in pancreatic neuroendocrine tumors : NEUROENDOCRINE TUMORSRAYMOND, Eric; HAMMEL, Pascal; DREYER, Chantal et al.Targeted oncology. 2012, Vol 7, Num 2, pp 117-125, issn 1776-2596, 9 p.Article

Time-specific blockade of PDGFR with Imatinib (Glivec®) causes cataract and disruption of lens fiber cells in neonatal miceZHOU, Yin-Pin; HE, Yang-Tao; CHEN, Cheng-Li et al.Virchows Archiv. 2011, Vol 458, Num 3, pp 349-356, issn 0945-6317, 8 p.Article

Will Antiangiogenic Agents be a Future for Mesothelioma Therapy?BELLI, C; ANAND, S; PANELLA, M et al.Current medicinal chemistry. 2010, Vol 17, Num 27, pp 3069-3079, issn 0929-8673, 11 p.Article

Molecular Analysis of PDGFRA and PDGFRB Genes by Rapid Single-strand Conformation Polymorphism (SSCP) in Patients with Core-binding Factor Leukaemias with KIT or FLT3 MutationTROJANI, Alessandra; BARBARA RIPAMONTI, Carla; PEZZETTI, Laura et al.Anticancer research. 2008, Vol 28, Num 5A, pp 2745-2751, issn 0250-7005, 7 p.Article

Pleuro-pulmonary Solitary Fibrous Tumors : A Clinicopathologic, Immunohistochemical, and Molecular Study of 88 Cases Confirming the Prognostic Value of de Perrot Staging System and p53 Expression, and Evaluating the Role of c-kit, BRAF, PDGFRs (α/β), c-met, and EGFRSCHIROSI, Laura; LANTUEJOUL, Sylvie; CAVAZZA, Alberto et al.The American journal of surgical pathology. 2008, Vol 32, Num 11, pp 1627-1642, issn 0147-5185, 16 p.Article

Gastrointestinal stromal tumours : three perspectives on current diagnosis and therapyBLANKE, Charles D.European journal of cancer. Supplement (1990). 2006, Vol 4, Num 3, pp 1-3, issn 1359-6349, 3 p.Article